Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Boye

Showing results (121-130 of 190) with videos related to

Pageof 19
Sort By:
The American Journal of Pathology|March 21, 1998
Somatic deletion of the 5' ends of both the COL4A5 and COL4A6 genes in a sporadic leiomyoma of the esophagusL Heidet, E Boye, Y Cai, et al.
Gene Therapy|July 26, 2023
Correction: Site-specific modifications to AAV8 capsid yields enhanced brain transduction in the neonatal MPS IIIB mouseJanine A Gilkes, Benjamin L Judkins, Brontie N Herrera, et al.
Human Gene Therapy|September 12, 2015
Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus After Intravenous InjectionDaniel M Lipinski, Chris A Reid, Sanford L Boye, et al.
Gene Therapy|January 25, 2013
Retinal gene therapy with a large MYO7A cDNA using adeno-associated virusV S Lopes, S E Boye, C M Louie, et al.
Journal of Theoretical Biology|May 21, 1994
Cell cycle control: prokaryotic solutions to eukaryotic problems?V Norris, J A Ayala, K Begg, et al.
Gene Therapy|November 27, 2020
Site-specific modifications to AAV8 capsid yields enhanced brain transduction in the neonatal MPS IIIB mouseJanine A Gilkes, Benjamin L Judkins, Brontie N Herrera, et al.
Human Gene Therapy|March 11, 2022
Gene Therapy in <i>Opn1mw</i> Mice and Implications for Blue Cone Monochromacy Patients with Deletion MutationsXiajie Ma, Emily R Sechrest, Diego Fajardo, et al.
Investigative Ophthalmology & Visual Science|July 23, 2011
Long-term preservation of cone photoreceptors and restoration of cone function by gene therapy in the guanylate cyclase-1 knockout (GC1KO) mouseSanford L Boye, Thomas Conlon, Kirsten Erger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2013
Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)C Obasaju, L Bowman, P Wang, et al.
Plos One|July 2, 2010
Functional and behavioral restoration of vision by gene therapy in the guanylate cyclase-1 (GC1) knockout mouseShannon E Boye, Sanford L Boye, Jijing Pang, et al.
Pageof 19

Showing results (121-130 of 190) with videos related to

Sort By:
Pageof 19
The American Journal of Pathology|March 21, 1998
Somatic deletion of the 5' ends of both the COL4A5 and COL4A6 genes in a sporadic leiomyoma of the esophagusL Heidet, E Boye, Y Cai, et al.
Gene Therapy|July 26, 2023
Correction: Site-specific modifications to AAV8 capsid yields enhanced brain transduction in the neonatal MPS IIIB mouseJanine A Gilkes, Benjamin L Judkins, Brontie N Herrera, et al.
Human Gene Therapy|September 12, 2015
Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus After Intravenous InjectionDaniel M Lipinski, Chris A Reid, Sanford L Boye, et al.
Gene Therapy|January 25, 2013
Retinal gene therapy with a large MYO7A cDNA using adeno-associated virusV S Lopes, S E Boye, C M Louie, et al.
Journal of Theoretical Biology|May 21, 1994
Cell cycle control: prokaryotic solutions to eukaryotic problems?V Norris, J A Ayala, K Begg, et al.
Gene Therapy|November 27, 2020
Site-specific modifications to AAV8 capsid yields enhanced brain transduction in the neonatal MPS IIIB mouseJanine A Gilkes, Benjamin L Judkins, Brontie N Herrera, et al.
Human Gene Therapy|March 11, 2022
Gene Therapy in <i>Opn1mw</i> Mice and Implications for Blue Cone Monochromacy Patients with Deletion MutationsXiajie Ma, Emily R Sechrest, Diego Fajardo, et al.
Investigative Ophthalmology & Visual Science|July 23, 2011
Long-term preservation of cone photoreceptors and restoration of cone function by gene therapy in the guanylate cyclase-1 knockout (GC1KO) mouseSanford L Boye, Thomas Conlon, Kirsten Erger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2013
Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)C Obasaju, L Bowman, P Wang, et al.
Plos One|July 2, 2010
Functional and behavioral restoration of vision by gene therapy in the guanylate cyclase-1 (GC1) knockout mouseShannon E Boye, Sanford L Boye, Jijing Pang, et al.
Pageof 19